A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol ; volume:20 ; number:1 ; day:6 ; month:8 ; year:2020 ; pages:1-9 ; date:12.2020
BMC psychiatry ; 20, Heft 1 (6.8.2020), 1-9, 12.2020
- Creator
-
Maier, Alice
Dharan, Anita
Oliver, Gina
Berk, Michael
Redston, Suzy
Back, Sudie E.
Kalivas, Peter
Ng, Chee
Kanaan, Richard A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12888-020-02793-9
- URN
-
urn:nbn:de:101:1-2020100120104912558578
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maier, Alice
- Dharan, Anita
- Oliver, Gina
- Berk, Michael
- Redston, Suzy
- Back, Sudie E.
- Kalivas, Peter
- Ng, Chee
- Kanaan, Richard A.
- SpringerLink (Online service)
Other Objects (12)
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
Tobacco smoking predicts depression and poorer quality of life in heart disease
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
Tobacco smoking predicts depression and poorer quality of life in heart disease
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
Tobacco smoking predicts depression and poorer quality of life in heart disease